Glanzmann Thrombasthenia Panel
GTR Test Accession: Help GTR000600523.1
NYS CLEP
INHERITED DISEASEHEMATOLOGY
Last updated in GTR: 2022-10-25
Last annual review date for the lab: 2023-06-08 LinkOut
At a Glance
Risk Assessment; Prognostic; Mutation Confirmation; ...
Glanzmann thrombasthenia
Genes (2): Help
ITGA2B (17q21.31), ITGB3 (17q21.32)
Molecular Genetics - Deletion/duplication analysis: Comparative Genomic Hybridization; ...
This panel is designed for the detection of germline variants …
Not provided
Not provided
Ordering Information
Offered by: Help
Versiti Diagnostic Laboratories
View lab's website
View lab's test page
Specimen Source: Help
  • Buccal swab
  • Cord blood
  • Bone marrow
  • Amniocytes
  • Isolated DNA
  • Fetal blood
  • Peripheral (whole) blood
  • Amniotic fluid
  • White blood cell prep
  • View specimen requirements
Who can order: Help
  • Nurse Practitioner
  • Licensed Physician
  • Genetic Counselor
  • Health Care Provider
  • Registered Nurse
Test Order Code: Help
CPT codes: Help
**AMA CPT codes notice
Lab contact: Help
Stefanie Dugan, MS, CGC, Certified Genetic counselor, CGC, Genetic Counselor
SDugan@Versiti.org
(414) 937-6126
Contact Policy: Help
Laboratory can only accept contact from health care providers. Patients/families are encouraged to discuss genetic testing options with their health care provider.
How to Order: Help
Test development: Help
Test developed by laboratory (no manufacturer test name)
Informed consent required: Help
Based on applicable state law
Pre-test genetic counseling required: Help
Decline to answer
Post-test genetic counseling required: Help
Decline to answer
Recommended fields not provided:
Conditions Help
Total conditions: 1
Condition/Phenotype Identifier
Test Targets
Genes Help
Total genes: 2
Gene Associated Condition Germline or Somatic Allele (Lab-provided) Variant in NCBI
Methodology
Total methods: 2
Method Category Help
Test method Help
Instrument *
Deletion/duplication analysis
Comparative Genomic Hybridization
Sequence analysis of the entire coding region
Next-Generation (NGS)/Massively parallel sequencing (MPS)
* Instrument: Not provided
Clinical Information
Test purpose: Help
Risk Assessment; Prognostic; Mutation Confirmation; Diagnosis
Target population: Help
This panel is designed for the detection of germline variants in 2 genes known to cause Glanzmann thrombasthenia.
Recommended fields not provided:
Technical Information
Availability: Help
Tests performed
Entire test performed in-house
Analytical Validity: Help
The analytical sensitivity of the NGS test is >99% for single nucleotide changes and insertions and deletions of less than 20 bp.
Assay limitations: Help
NGS analysis is not designed to detect large deletions or duplications (>20 bp), or variants that are outside the regions sequenced. Low level mosaicism will not be detected by this sequencing methodology.
Proficiency testing (PT):
Is proficiency testing performed for this test? Help
No
Recommended fields not provided:
Regulatory Approval
FDA Review: Help
Category: Not Applicable
NYS CLEP Approval: Help
Number: 68479
Status: Approved
Additional Information

IMPORTANT NOTE: NIH does not independently verify information submitted to GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.